NextGen researcher profile: Carolyn Anderson

Carolyn Anderson has spent more than 30 years developing targeted therapies for diseases like cancer and sickle cell disease. See how she will help drive research efforts for NextGen Precision Health.

March 3, 2021
Updated July 28, 2021

Carolyn Anderson, Simón-Ellebracht Professor in Medicinal Chemistry and professor of radiology at the University of Missouri, is a world-class radiopharmaceutical researcher who has devoted her career to improving diagnostic imaging and treating diseases such as cancer and sickle cell disease.

As part of the NextGen Precision Health initiative, Anderson and her lab will lead the Molecular Imaging and Theranostics Center in developing targeted radiopharmaceutical therapy agents, either alone or in combination with immune-based therapies, to battle melanoma and other types of cancer. The goal is to kill cancer cells with less damage to the body — improving the patient’s quality of life.

In this video:
  • Carolyn Anderson: Simón-Ellebracht Professor in Medicinal Chemistry; professor of radiology
  • Richard Barohn: Executive vice chancellor for health affairs; executive director, NextGen Precision Health
  • Patricia Okker: Former dean, College of Arts and Science

Subscribe to

Show Me Mizzou

Stay up-to-date with the latest news by subscribing to the Show Me Mizzou newsletter.